1. Home
  2. SY vs GALT Comparison

SY vs GALT Comparison

Compare SY & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo So-Young International Inc. American Depository Shares

SY

So-Young International Inc. American Depository Shares

HOLD

Current Price

$2.63

Market Cap

289.0M

Sector

Technology

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$3.15

Market Cap

261.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SY
GALT
Founded
2013
2000
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
289.0M
261.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SY
GALT
Price
$2.63
$3.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.50
$8.50
AVG Volume (30 Days)
552.0K
787.4K
Earning Date
11-17-2025
11-14-2025
Dividend Yield
1.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$201,132,009.00
N/A
Revenue This Year
$6.36
N/A
Revenue Next Year
$57.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.67
$1.07
52 Week High
$6.28
$7.13

Technical Indicators

Market Signals
Indicator
SY
GALT
Relative Strength Index (RSI) 41.57 28.13
Support Level $2.46 $3.34
Resistance Level $3.00 $4.35
Average True Range (ATR) 0.15 0.38
MACD 0.01 -0.13
Stochastic Oscillator 34.55 12.96

Price Performance

Historical Comparison
SY
GALT

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: